Paragon 28, Inc. (FNA) recently launched the R3FLEX Stabilization System, designed to restore stability to the ankle syndesmosis after suffering an injury from an ankle fracture or high ankle sprain.The latest innovation is aimed at strengthening the company’s syndesmotic injury repair portfolio. As predicted, the R3FLEX Stabilization System will be used to treat 470 million ankle fractures in the United States in 2024.Following the launch, shares of Paragon 28 lost 12% on Friday. However, as FNA is gaining ...